InvestSMART

ResMed Inc. (ASX: RMD) - Announcements

Current share price for RMD : $28.870 2.61 (8.29%)+

ASX company news and announcements for ResMed Inc. (RMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ResMed Inc. (RMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ResMed Inc. (RMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ResMed Inc. (RMD)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$17,072 FORM SD 27 May 2021 2:15PM $26.640 $28.870 risen by 8.37%
$17,072 FORM S-8 24 May 2021 9:29AM $25.970 $28.870 risen by 11.17%
$17,072 Update - Dividend/Distribution - RMD 14 May 2021 2:08PM $25.270 $28.870 risen by 14.25%
$17,072 Chess Depositary Interest - RMD 6 May 2021 10:21AM $24.620 $28.870 risen by 17.26%
$17,072 FORM 10Q For Qtr ended March, 2021 3 May 2021 9:07AM $26.170 $28.870 risen by 10.32%
$17,072 Dividend/Distribution - RMD 30 Apr 2021 8:10AM $27.320 $28.870 risen by 5.67%
$17,072 ResMed Announces Results for the Third Quarter of FY2021 30 Apr 2021 8:10AM $27.320 $28.870 risen by 5.67%
$17,072 RMD to Report Third Quarter Fiscal 2021 Results 9 Apr 2021 8:21AM $26.020 $28.870 risen by 10.95%
$17,072 Chess Depositary Interest - RMD 7 Apr 2021 8:54AM $25.560 $28.870 risen by 12.95%
$17,072 Form 10-K/A - Amendment No. 1 31 Mar 2021 8:20AM $25.040 $28.870 risen by 15.30%
$17,072 Chess Depositary Interest - RMD 4 Mar 2021 2:57PM $24.275 $28.870 risen by 18.93%
$17,072 Update - Dividend/Distribution - RMD 12 Feb 2021 12:10PM $25.760 $28.870 risen by 12.07%
$17,072 Chess Depositary Interest - RMD 4 Feb 2021 4:10PM $26.510 $28.870 risen by 8.90%
$17,072 FORM 10Q for Qtr ended December, 2020 1 Feb 2021 9:34AM $27.220 $28.870 risen by 6.06%
$17,072 Dividend/Distribution - RMD 29 Jan 2021 8:25AM $27.420 $28.870 risen by 5.29%
$17,072 ResMed Announces Results for the Second Quarter of FY2021 29 Jan 2021 8:25AM $27.420 $28.870 risen by 5.29%
$17,072 RMD to Report Second Quarter Fiscal 2021 Results 8 Jan 2021 8:49AM $27.000 $28.870 risen by 6.93%
$17,072 Chess Depositary Interest - RMD 6 Jan 2021 12:19PM $27.300 $28.870 risen by 5.75%
$17,072 Chess Depositary Interest - RMD 4 Dec 2020 3:18PM $27.810 $28.870 risen by 3.81%
$17,072 FORM 8-K Annual Meeting Stockholders 23 Nov 2020 11:38AM $28.940 $28.870 fallen by 0.24%
$17,072 Update - Dividend/Distribution - RMD 13 Nov 2020 10:40AM $29.540 $28.870 fallen by 2.27%
$17,072 FORM-8K/A 11 Nov 2020 10:04AM $29.490 $28.870 fallen by 2.10%
$17,072 Chess Depositary Interest - RMD 5 Nov 2020 9:27AM $28.490 $28.870 risen by 1.33%
$17,072 FORM 10Q for Qtr ended September, 2020 2 Nov 2020 9:04AM $27.920 $28.870 risen by 3.40%
$17,072 Dividend/Distribution - RMD 30 Oct 2020 8:23AM $25.510 $28.870 risen by 13.17%

401 - 425 of 708 results

Page 17 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.